文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Iron Dysregulation in Cardiovascular Diseases.

作者信息

Wang Hui, Huang Zhongmin, Du Chenyan, Dong Mingqing

机构信息

Geriatric Diseases Institute of Chengdu, Center for Medicine Research and Translation, Chengdu Fifth People's Hospital, 611137 Chengdu, Sichuan, China.

出版信息

Rev Cardiovasc Med. 2024 Jan 10;25(1):16. doi: 10.31083/j.rcm2501016. eCollection 2024 Jan.


DOI:10.31083/j.rcm2501016
PMID:39077672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11263000/
Abstract

Iron metabolism plays a crucial role in various physiological functions of the human body, as it is essential for the growth and development of almost all organisms. Dysregulated iron metabolism-manifested either as iron deficiency or overload-is a significant risk factor for the development of cardiovascular disease (CVD). Moreover, emerging evidence suggests that ferroptosis, a form of iron-dependent programed cell death, may also contribute to CVD development. Understanding the regulatory mechanisms of iron metabolism and ferroptosis in CVD is important for improving disease management. By integrating different perspectives and expertise in the field of CVD-related iron metabolism, this overview provides insights into iron metabolism and CVD, along with approaches for diagnosing, treating, and preventing CVD associated with iron dysregulation.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceab/11263000/4c09b2c73112/2153-8174-25-1-016-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceab/11263000/4c9cd7bb5a01/2153-8174-25-1-016-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceab/11263000/07a990481993/2153-8174-25-1-016-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceab/11263000/d8da457f9c3f/2153-8174-25-1-016-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceab/11263000/467064efa350/2153-8174-25-1-016-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceab/11263000/4c09b2c73112/2153-8174-25-1-016-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceab/11263000/4c9cd7bb5a01/2153-8174-25-1-016-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceab/11263000/07a990481993/2153-8174-25-1-016-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceab/11263000/d8da457f9c3f/2153-8174-25-1-016-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceab/11263000/467064efa350/2153-8174-25-1-016-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceab/11263000/4c09b2c73112/2153-8174-25-1-016-g5.jpg

相似文献

[1]
Iron Dysregulation in Cardiovascular Diseases.

Rev Cardiovasc Med. 2024-1-10

[2]
A Panoramic View of Ferroptosis in Cardiovascular Disease.

Kidney Dis (Basel). 2023-3-15

[3]
Herbal medicines provide regulation against iron overload in cardiovascular diseases: Informing future applications.

J Ethnopharmacol. 2024-5-23

[4]
From Iron Metabolism to Ferroptosis: Pathologic Changes in Coronary Heart Disease.

Oxid Med Cell Longev. 2022

[5]
Dysregulation of iron metabolism in cardiovascular diseases: From iron deficiency to iron overload.

Biochem Pharmacol. 2021-8

[6]
Decoding ferroptosis: Revealing the hidden assassin behind cardiovascular diseases.

Biomed Pharmacother. 2024-7

[7]
Non-coding RNA-mediated modulation of ferroptosis in cardiovascular diseases.

Biomed Pharmacother. 2023-8

[8]
The Impacts of Iron Overload and Ferroptosis on Intestinal Mucosal Homeostasis and Inflammation.

Int J Mol Sci. 2022-11-17

[9]
Ferroptosis in cardiovascular disease.

Biomed Pharmacother. 2024-1

[10]
Targeting Iron Metabolism and Ferroptosis as Novel Therapeutic Approaches in Cardiovascular Diseases.

Nutrients. 2023-1-23

引用本文的文献

[1]
Emerging trends in cardiovascular diseases: the impact of ferroptosis and cuproptosis on cardiomyocyte death.

Mol Cell Biochem. 2025-6-23

本文引用的文献

[1]
Iron(III)-based metalloradical catalysis for asymmetric cyclopropanation via a stepwise radical mechanism.

Nat Chem. 2023-11

[2]
Ferroptosis contributes to catecholamine-induced cardiotoxicity and pathological remodeling.

Free Radic Biol Med. 2023-10

[3]
Nutritional Aspects of Iron in Health and Disease.

Nutrients. 2023-5-24

[4]
Haemochromatosis.

Lancet. 2023-5-27

[5]
A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.

Kidney Int. 2023-7

[6]
Relationship between ferroptosis and mitophagy in cardiac ischemia reperfusion injury: a mini-review.

PeerJ. 2023

[7]
Quantification of Liver Iron Overload with MRI: Review and Guidelines from the ESGAR and SAR.

Radiology. 2023-4

[8]
Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets.

Circ Res. 2023-2-3

[9]
Duality of Nrf2 in iron-overload cardiomyopathy.

Haematologica. 2023-5-1

[10]
The role of iron homeostasis in remodeling immune function and regulating inflammatory disease.

Sci Bull (Beijing). 2021-9-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索